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as previously described [2,4,5].
Rats were heparinized before being sacriﬁced by carbon dioxide inha-
lation and cervical dislocation. Theheartswere rapidly excised following a
mid-line thoracotomy, and the aorta was cannulated using a Langendorff
apparatus, perfused retrogradely at constant ﬂow with Krebs–Henseleit
modiﬁed buffer (in mmol/L: 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.25 CaCl2, 25
NaHCO3, 1.2 KH2PO4, and 11 glucose), and equilibrated with 95% O2/5%
CO2 gas mixture at 37.0 ± 0.5 °C. A water-ﬁlled latex balloon was placed
into the left ventricle (LV) through the mitral valve and connected to a
pressure transducer and PowerLab System (ADInstruments, Australia)
for continuous LV pressure recording. The heart was kept immersed in aStressful events during gestation and lactation have a strong correla-
tion to the development of adult diseases such as obesity and cardiovas-
cular failure [1]. High serum concentrations of leptin in the ﬁrst 10 days
of lactation were associated with hyperleptinemia at 150 days of age
and also with a higher food intake and body weight [2]. These data re-
ﬂect a resistance to the anorectic effect of leptin, as observed for animals
whose mothers were exposed to malnutrition during lactation [2,3].
Trevenzoli et al. had previously described that leptin treatment dur-
ing the ﬁrst 10 days of lactation increased catecholamine synthesis and
secretion [4]. Echocardiographic studies have shown cardiac dysfunc-
tion compatible with diastolic heart failure in this experimental model
in early age that evolved to systolic dysfunction in adulthood [5]. The
aim of the present work was to study the spontaneous cardiac activity
of isolatedheart preparations from rats at 30 and150days of age treated
with leptin during the ﬁrst 10 days of lactation, also investigating their
response to β-adrenergic stimulation.
This study was performed at the Laboratory of Experimental Phar-
macology of Fluminense Federal University and approved by local Ethics
Committee (CEPA/UFF00123-09). Wistar rats were treated with leptin
(PeproTech Inc., London, UK) at a dose of 8 mg/100 g body weightl Pharmacology, Department of
versity, Rua Professor Hernani
EP 24.210-130, Brazil.
retas@gmail.com
.daily for the ﬁrst 10 days of lactation or saline (Control-Leptin naïve)
buffer-ﬁlledwater jacketed glass chamber, and the end-diastolic pressure
(LVEDP) was adjusted to 10 mm Hg. LV developed pressure (LVDP) was
determined as the difference between the peak systolic and LVEDP [6].
Cardiac performance indexes such as LV contractility rate (assessed
by+dp/dt) and LV relaxation rate (assessed by−dp/dt)were also deter-
mined. After stabilization and basal parameters recording, the hearts
were subjected to increasing concentrations of isoprenaline (1, 10 and
100nM), a non-selective β-agonist [7].
All data are expressed as mean ± SEM. A two-tailed unpaired
Student's t-test was performed and statistical signiﬁcance was accepted
at the 0.05 level (Graph-Pad Prism 5.0).
Fig. 1 shows spontaneous response of isolated heart preparations
from rats at 30 and 150 days of age. Analyzing the left ventricle relaxa-
tion rate it is possible to observe that the hearts of rats at 30 days of age
submitted to neonatal leptin treatment presented a lower spontaneous
lusitropic activity when compared to control, without changes of spon-
taneous inotropic activity. These data corroborates the diastolic dys-
function suggested by Marques et al. in this experimental model [5].
Heart preparations from rats at 150 days of age of Leptin group present-
ed a lower spontaneous inotropic activity when compared to control,
considering both LV developed pressure as the systolic contractility
rate (Fig. 1). These data also corroborate the ﬁndings of Marques et al.
whose echocardiographic studies have inferred a systolic dysfunction
in these older animals [5].
Given the important role of sympathetic activity in the pathophysi-
ology of heart failure [8], the concentration-dependent response to iso-
prenaline of perfused hearts was also evaluated (Table 1). Preparations
from rats of Leptin group at 30 days of age showed a greater increase of
LV developed pressure, as well as of both cardiac performance indexes,
with 100 nM isoprenaline. On the other hand, it was just observed a
Fig. 1. Spontaneous response of heart preparations from rats that receive saline (Control-Leptin naive-gray bars) or leptin (Leptin-black bars) during lactation at 30 (n = 4) and
150 (n= 4-7) days of age. The analyzed parameters were (A) left ventricular developed pressure, (B) left ventricular contractility rate, (C) left ventricular relaxation rate. Values
are mean ± SEM. *P b 0.05 or ** P b 0.001-Leptin vs Control.
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in hearts from older animals. These data are also in accordance to
Marques et al. whose electrocardiographic studies suggested the raise
of sympathetic response [5].
Physiological sympathetic stimulation of the heart through β-
adrenergic receptors is related to developed contraction rise, relaxation
acceleration and intracellular calcium concentration decline [9]. Stimula-
tion of β-adrenergic receptor activates a GTP-binding (G) protein, which
stimulates adenylyl cyclase to produce cAMP, which in turn activates
PKA. This kinase phosphorylates several proteins related to excitation–
contraction coupling [9].
Heart failure is characterized by a complex interplay of several neuro-
hormonalmechanisms that get activated in the syndrome in order to sus-
tain cardiac output in the face of decompensating function. Perhaps the
most prominent among these mechanisms is the sympathetic nervous
system. Acutely this rise of the adrenergic activity will promptly restore
cardiac function [8]. In offspring of obese dams, systolic and diastolic dys-
functionwas associatedwith cardiac sympathetic dominance that can be
explained by upregulation of β1 adrenergic receptors [7]. So, as Marques
et al. described a diastolic dysfunctionwith preserved ejection fraction in
rats at 30 days of age submitted to neonatal leptin treatment that evolves
to systolic dysfunction in rats at 150 days of age [5] and as the data from
Langendorff assay is obtained using denervated hearts, we postulate that
the greater response to isoprenaline of heart preparations from the youn-
ger Leptin groupmay be due to the rise ofβ1-adrenergic receptor expres-
sion and/or of efﬁcacy of its intracellular signaling machinery. However,
hyperstimulation or overexpression of β1-adrenergic receptor has detri-
mental effects in the heart [8]. In systolic heart failure cardiac β-
adrenergic dysfunction is generally characterized at the molecular levelTable 1
Effect of isoprenaline on the spontaneous response of heart preparations from rats at 30 and 15






1 nM 16.8 ± 3.5 26.7 ± 2.6
10 nM 42.4 ± 9.8 61.7 ± 12
100 nM 70.9 ± 6.5 129.6 ± 22
+dp/dt (% basal)
1 nM 463.4 ± 10.1 466.1 ± 49
10 nM 650.7 ± 66.4 869.6 ± 52
100 nM 847.6 ± 21.5 1034.4 ± 24
−dp/dt (% basal)
1 nM −617.0 ± 18.8 −673.4 ± 15
10 nM −861.5 ± 73.3 −1109.8 ± 65
100 nM −1054.1 ± 37.1 −1330.3 ± 27
LVDP — left ventricular developed pressure; +dp/dt — left ventricular contractility rate;−dp/
*P b 0.05 or ** P b 0.001 — Leptin vs Control.by selective β1-adrenergic receptor downregulation and by uncoupling
of the remaining receptors from G proteins [8], which may explain the
absence of a greater effect of isoprenaline on LV developed pressure
and on LV relaxation rate in the older Leptin group. As the ability of sym-
pathetic nervous system to maintain cardiac function decreases in the
course of chronic heart failure, sympathomimetics used as positive
inotropes for acute heart failure signiﬁcantly increase mortality if used
chronically [8]. Several major trials have established the cardiovascular
beneﬁts of carvedilol, a β-blocker, in patients with heart failure and this
drug is currently used in the pharmacotherapy of heart failure with sys-
tolic dysfunction [10].
Thus, our data suggest that spontaneous and sympathetic response
of isolated heart preparations from rats submitted to neonatal leptin
treatment are compatible with the diastolic heart failure in youth that
evolves to systolic dysfunction in adulthood previously described [5].
Studies are in course to precisely delineate themolecular and biochem-
ical mechanisms underlying these changes in order to discuss new
pharmacological approaches for heart failure.
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10.5 ± 2.8 13.6 ± 3.0
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